383 results on '"Pawlik, T.M."'
Search Results
152. Scientific Impact of AAS/SUS Plenary Session Abstracts Increases in the Era of the Joint Academic Surgical Congress, 2006-2010
153. 3634 POSTER European Priorities for Hepatocellular Carcinoma (HCC) Control: a Comparison of Current Needs in Five Countries
154. National Trends In The Surgical Management And Survival Of Patients With Colorectal Liver Metastasis: A Population-Based Analysis
155. The Role Of Liver Directed Surgery In Patients With Hepatic Metastasis From A Gynecologic Primary Carcinoma: A Comprehensive Single-Institution Study of 87 Patients
156. Stereotactic Radiation Treatment Planning with Volumetric Modulated Arc Therapy (VMAT): Impact of Duodenal Sparing
157. Proximal Cholangiocarcinoma: Tumor Depth Predicts Outcome
158. Comparison of Two Adjuvant Chemoradiotherapy Protocols after Resection of Primary Pancreatic Carcinoma: A 10 Year Experience
159. Adjuvant Chemoradiation for Adenocarcinoma of the Body and Tail of the Pancreas: The Johns Hopkins Experience
160. Adjuvant Therapy for Gallbladder Carcinoma: The Johns Hopkins Experience
161. QS323. Total Pancreatectomy for Pancreatic Adenocarcinoma: Evaluation of Morbidity and Long-Term Outcome
162. QS316. Predictors of Long-Term Survival After Distal Pancreatectomy for Pancreatic Adenocarcinoma
163. QS322. Is it Safe to Observe Asymptomatic Branch Duct or Mixed-Type Intraductal Papillary Mucinous Neoplasms (IPMN) Less Than 3CM and Without a Solid Component?: The Pathological Findings of 16 Patients Who Underwent Pancreatectomy for This Condition
164. 194. Staging Distal Cholangiocarcinoma: Tumor Depth Not AJCC T Classification Determines Outcome
165. Benefit of Adjuvant Chemoradiation Therapy for Ampullary Adenocarcinoma: The Johns Hopkins Hospital - Mayo Clinic Collaborative Study
166. Adjuvant Therapy for Ampullary Adenocarcinoma: The Johns Hopkins Experience
167. Adjuvant Chemoradiation Therapy after Surgical Resection for 1092 Cases of Pancreatic Adenocarcinoma: The Johns Hopkins Hospital - Mayo Clinic Collaborative Study of Pancreatic Cancer
168. Adjuvant Chemoradiation Therapy After Pancreaticoduodenectomy in Elderly Patients With Pancreatic Adenocarcinoma
169. Gemcitabine-Based Chemoradiation for Locally Advanced Unresectable Adenocarcinoma of the Pancreas: Effect of Nodal Volume Coverage and Chemotherapy Dose on Treatment Related Toxicity and Outcome
170. Clinicopathologic Review of Resected Pancreatic Adenosquamous Carcinoma: Importance of Adjuvant Chemotherapy and Radiation
171. Synchronous colorectal liver metastasis: A network meta-analysis review comparing classical, combined, and liver-first surgical strategies.
172. Re: Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma, Thomas and Clark
173. National implementation and outcomes of robotic pancreaticoduodenectomy.
174. Value of lymph node dissection in intrahepatic cholangiocarcinoma: a systematic review and meta-analysis.
175. Laparoscopic approach reduces the incidence of postoperative pulmonary complications after hepatectomy for hepatocellular carcinoma: a multicenter overlap propensity score-weighted analysis.
176. Perioperative changes of serum transaminase levels on postoperative morbidity following liver resection for hepatocellular carcinoma.
177. The influence of socioeconomic inequity on guidelines compliance and mortality of patients with acute biliary pancreatitis. An international multicentric cohort study.
178. Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced-stage hepatocellular carcinoma: a prospective multicenter propensity matching analysis.
179. Development and validation of nomograms to predict survival and recurrence following hepatectomy for intermediate/advanced (BCLC stage B/C) hepatocellular carcinoma.
180. Chronological and geographical variations in the incidence of COVID-19 positive donors.
181. Association of preoperative frailty with short-term and long-term surgical outcomes following hepatectomy for elderly patients with hepatocellular carcinoma.
182. Prognostic significance of postoperative serological incomplete conversion of AFP and PIVKA-II following curative-intent resection for hepatocellular carcinoma: a multicenter analysis of 1,755 patients.
183. Telemedicine use by medicare beneficiaries undergoing hepatopancreatic surgery during COVID-19.
184. The impact of persistence of poverty on hepatopancreaticobiliary cancer.
185. Long-term follow-up of hepatic adenoma and adenomatosis: analysis of size change on imaging with histopathological correlation.
186. Hepatopancreatic versus hepatic/pancreatic surgeons: Does subspecialization impact patient outcomes?
187. The impact of hospital volume on the outcomes of minimally invasive hepatectomy for HCC.
188. Clinical Features of Recurrence After Hepatic Resection for Early-stage Hepatocellular Carcinoma and Long-term Survival Outcomes of Patients with Recurrence - A Multi-institutional Analysis contained 1424 cases.
189. Using Machine Learning to Preoperatively Stratify Prognosis among Patients with Gallbladder Cancer: A Multi-Institutional Analysis.
190. Clinical Burden of ICU Admissions in Patients with Previous Resection of Pancreatic Cancer.
191. Tumor necrosis impacts prognosis of patients undergoing resection for T1 intrahepatic cholangiocarcinoma: implications for modification of 8th AJCC T classification.
192. Clinical burden of ICU admission among patients undergoing resection of pancreatic cancer.
193. Real-time mortality risk calculator following pancreatoduodenectomy: quantifying the impact of perioperative events.
194. Social vulnerability profiles are associated with varied outcomes among patients undergoing hepatopancreatic resection.
195. Social vulnerability and fragmentation of postoperative surgical care among patients undergoing hepatopancreatic surgery.
196. Repeat Hepatectomy for Early and Late Recurrence of Hepatocellular Carcinoma: A Multicenter Study with Propensity Score Matching Analysis.
197. Noninvasive Markers (ALBI and APRI) Predict Post-Hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma.
198. Effect of Performance Status on Short-term and Long-Term Outcomes After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study.
199. Parenchymal sparing versus anatomical hepatectomies in patients with multifocal (=4 tumors) colorectal liver metastasis: Results of an international multi-institutional analysis.
200. The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.